Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal Amphotericin B (Ambisome)
Russo R., Nigro L., Minniti S., et al. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal Amphotericin B (Ambisome). J. Infect. 32, 133-137, 1996.
Visceral leishmaniasis and HIV co-infection in Southern France
Rosenthal E., Marty P., Poizot-Martin I., et al. Visceral leishmaniasis and HIV co-infection in Southern France. Trans R Soc Trop Med Hyg; 89, 159-162, 1995.
Anal ulcer and chronic diarrhoea as manifestations of visceral leishmaniasis in a patient infected with human immunodeficency virus
Pèrez-Molina J, Fortùn J., Lòpez-Vélè z R. Anal ulcer and chronic diarrhoea as manifestations of visceral leishmaniasis in a patient infected with human immunodeficency virus. Trans. R. Soc. Trop. Med. Hyg. 91, 436-437, 1997.
In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from HIV/Leishmania co-infected subjects
Nigro L., Cacopardo B., Preiser W., et al In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from HIV/Leishmania co-infected subjects. Am. J. Trop. Med. Hyg. 60, 142-145, 1999.